“CAR-T & Cell Therapy” — FilingIndex Search

Filter

27 of 3,901

Sort

AZNASTRAZENECA PLC🔥

Healthcare · Pharmaceuticals

$277.22B-0.7%

P/E 46.5·P/S 6.1·Mgn 13.0%·ROE 21.0%·FCF 4.2%

—

LEGNLegend Biotech Corp⚡

Healthcare · Pharmaceuticals

$6.66B-1.7%

P/E —·P/S 56.9·Mgn -381.5%·ROE -29.6%·FCF -1.9%

—

NKTRNEKTAR THERAPEUTICS

Healthcare · Pharmaceuticals

$2.01B+6.8%

P/E —·P/S 36.1·Mgn -284.2%·ROE -182.6%·FCF -10.4%

F 3

Red 8-K

NTLAIntellia Therapeutics, Inc.⚡

Healthcare · Diagnostics & Tools

$1.69B+1.9%

P/E —·P/S 25.6·Mgn -597.0%·ROE -61.5%·FCF -23.4%

—

PGENPRECIGEN, INC.

Healthcare · Pharmaceuticals

$1.59B-3.7%

P/E —·P/S 50.2·Mgn -647.0%·ROE -1198.6%·FCF -5.7%

—

13DRed 8-K

CDNACareDx, Inc.

Healthcare · Healthcare Services

$1.19B-2.7%

P/E —·P/S 2.9·Mgn -2.0%·ROE -7.0%·FCF —

—

Red 8-K

MGTXMeiraGTx Holdings plc

Healthcare · Biotechnology

$888M+7.7%

P/E —·P/S 11.1·Mgn -151.1%·ROE —·FCF -5.7%

—

13D

CYRXCryoport, Inc.

Healthcare · Pharmaceuticals

$737M-3.6%

P/E 9.4·P/S 4.2·Mgn 44.4%·ROE 15.6%·FCF -3.4%

F 5

REPLReplimune Group, Inc.

Healthcare · Biotechnology

$733M-1.2%

P/E —·P/S —·Mgn —·ROE -59.5%·FCF —

—

CLYMClimb Bio, Inc.

Healthcare · Pharmaceuticals

$655M-2.4%

P/E —·P/S —·Mgn —·ROE -37.3%·FCF —

—

13DDilut.Red 8-K

IMMXImmix Biopharma, Inc.

Healthcare · Pharmaceuticals

$602M-1.7%

P/E —·P/S —·Mgn —·ROE -31.4%·FCF —

P/E —·P/S —·Mgn —·ROE -87.9%·FCF —

—

13DDilut.Red 8-K

CCCCC4 Therapeutics, Inc.

Healthcare · Biotechnology

$431M+7.4%

P/E —·P/S 12.0·Mgn -292.1%·ROE -40.9%·FCF -23.0%

—

Red 8-K

AUTLAutolus Therapeutics plc

Healthcare · Biotechnology

$415M-3.0%

P/E —·P/S 5.5·Mgn -381.4%·ROE -161.4%·FCF -72.9%

F 2

Red 8-K

IPSCCentury Therapeutics, Inc.

Healthcare · Biotechnology

$406M+1.7%

P/E —·P/S —·Mgn —·ROE -6.0%·FCF -25.8%

—

Red 8-K

INDPIndaptus Therapeutics, Inc.

Healthcare · Pharmaceuticals

$405M-2.0%

P/E —·P/S —·Mgn —·ROE -127.7%·FCF —

—

13DDilut.Red 8-K

GLSIGreenwich LifeSciences, Inc.

Healthcare · Pharmaceuticals

$353M+0.9%

P/E —·P/S —·Mgn —·ROE -5480.5%·FCF —

—

ELTXElicio Therapeutics, Inc.

Healthcare · Pharmaceuticals

$283M-2.3%

P/E —·P/S —·Mgn —·ROE -2418.8%·FCF —

—

RNACCartesian Therapeutics, Inc.

Healthcare · Pharmaceuticals

$279M+8.1%

P/E —·P/S 99.9·Mgn -4658.6%·ROE —·FCF -28.4%

—

13DDilut.Red 8-K

NKTXNkarta, Inc.

Healthcare · Pharmaceuticals

$205M-0.7%

P/E —·P/S —·Mgn —·ROE -33.3%·FCF -43.9%

—

13D

CRBUCaribou Biosciences, Inc.

Healthcare · Biotechnology

$158M-0.6%

P/E —·P/S 14.2·Mgn -1327.4%·ROE -121.2%·FCF -71.0%

—

MXCTMAXCYTE, INC.

Healthcare · Biotechnology

$120M-0.8%

P/E —·P/S 3.6·Mgn -135.1%·ROE -26.0%·FCF -30.2%

F 2

13DRed 8-K

CUECue Biopharma, Inc.

Healthcare · Pharmaceuticals

$103M+3.7%

P/E —·P/S 3.1·Mgn -59.6%·ROE -100.6%·FCF -21.2%

—

Dilut.Red 8-K

RPIDRAPID MICRO BIOSYSTEMS, INC.

Healthcare · Diagnostics & Tools

$88M0.0%

P/E —·P/S 2.6·Mgn -145.8%·ROE -141.9%·FCF -36.4%

—

ANIXAnixa Biosciences Inc

Healthcare · Pharmaceuticals

$84M-1.8%

P/E —·P/S —·Mgn —·ROE -79.1%·FCF —

—

IBIOiBio, Inc.

Healthcare · Pharmaceuticals

$84M+1.2%

P/E —·P/S —·Mgn —·ROE -123.5%·FCF -18.2%

P/E —·P/S —·Mgn —·ROE -488.5%·FCF -12.8%

F 3

13DRed 8-K

Filings · filterAll 10-K 10-Q 8-K S-1 DEF 14A SC 13D

Filings

40 shown

BRLSWBorealis Foods Inc.

10-Q

Quarterly report — three-month financials and management discussion.

Jun 30, 2026·18h ago

PRPHProPhase Labs, Inc.

10-Q

Quarterly report — three-month financials and management discussion.

Companies above the $50M market cap · $1 pricefloor; SPAC/shells hidden by default. Fundamentals & prices via Polygon · signals from SEC EDGAR — verify on SEC.gov. Filings current to Jun 30 · prices to Jun 30.